Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
04 May 2023 | Story Lunga Luthuli | Photo Supplied
Juanita
As a member of the USAf Leadership Management Strategy Group, Juanita Burjins will help member universities and other key role players with their leadership and management development needs.

Juanita Burjins, Head: Leadership and Development in the Department of Human Resources at the University of the Free State, was recently appointed as a member of the Universities South Africa’s Leadership Management Strategy Group (LMSG). The appointment to the group in April 2023 is a testament and a recognition of Burjin’s leadership and expertise, not only in the field of human resources but also in the higher education sector.

The LMSG is responsible for initiating activities that would allow it to develop evidence-based influences on the work of Higher Education Learner Management (HELM), and to advise the board on the programmatic direction of HELM, including its financial sustainability and identifying opportunities for the growth and expansion of its post-school education and training.

As a member of the USAf Leadership Management Strategy Group – a position Burjins will hold for three years – she will contribute and provide strategic advice to the USAf Board, the Chief Executive, and the Director of Higher Education Leadership and Management, regarding planning, implementation, and monitoring. 

Burjins said: “I was nominated by the Skills Development Facilitators Forum; in the group, I will be responsible for engagement and alignment with member universities and other key role players in terms of their leadership and management development needs.”  

Beaming with pride, Burjins is looking forward to “working with a group of expert leaders within the higher education sector and contributing to enabling and empowering learning opportunities”. 

“I am proud that I could represent the University of the Free State in this capacity and contribute to the stability and effectiveness of institutional leadership and management in the higher education sector. With the opportunity, I am also looking forward to providing strategic advice, advocacy, and tactical programme management support for HELM, and identifying potential national and regional collaborations and partnerships with other universities,” added Burjins.

Burjins believes it is important to have the USAf Leadership Management Strategy Group in higher education, as it provides ‘strategic advice to the USAf Board on the planning, implementation, and monitoring of HELM for the engagement and alignment of member universities in terms of the leadership and development needs as well as the relevance and responsiveness of programme offering and other services in leadership and development.

News Archive

UFS to monitor the use of ARV-drugs on pregnant women and children
2004-12-08

The University of the Free State (UFS) is to establish a Pharmacovigilance Centre that will monitor the effects of Anti-Retroviral (ARV) drugs on HIV positive pregnant women and children starting early in the new year.

The UFS is one of only two institutions chosen by the Minister of Health, Dr Manto Tshabalala-Msimang, to establish such an ARV monitoring centre.

The other centre will be based at Medical University of South Africa (MEDUNSA) and will concentrate mainly on monitoring the effects of the drugs on adults.

“The establishment of the UFS’s Pharmaconvigilance Centre forms part of government’s Comprehensive Plan on HIV and AIDS, often termed the roll-out plan for ARV drugs. The centre’s primary responsibility will be to specifically monitor the use of these drugs in pregnant women, and children under the age of 13,” said Prof Andrew Walubo of the UFS’s Department of Pharmacology.

“Although most of the side effects of ARV drugs have been identified in other countries, it has now become critical to identify the side effects amongst the South African population. This is important because many people will be exposed to the drugs within a short time. Our aim is so identify the most common side effects and make recommendations for the prevention thereof. The centre will help in detecting the risk of using anti-retroviral drugs in pregnancy and children, and prevention of adverse drug reactions,” said Prof Walubo.

According to Prof Walubo 12 drugs will be monitored – these drugs will be selected according to the patient’s profile.

The centre will comprise of two components: A pregnancy registry, which will focus on a new-born child up until two months and a pediatric registry, which will focus on children who are born of mothers who used ARV drugs and children using ARV drugs.

According to Prof Walubo, the Pharmaconvigilance Centre will also be responsible for offering relevant technical advice, training and selected research on ARV drugs in these patients.

The centre will be fully sponsored by the national Department of Health. It will be based in the UFS’s Faculty of Health Sciences, Department of Pharmacology, and will be run in collaboration with experts from different departments in the faculty.

Media release
Issued by: Lacea Loader
Media Representative
Tel: (051) 401-2584
Cell: 083 645 2454
E-mail: loaderl.stg@mail.uovs.ac.za
8 December 2004

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept